Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in

Ashish Sarraju1, Andrew Ward2, Sukyung Chung3

  • 1Division of Cardiovascular Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.

Open Heart
|October 20, 2021
PubMed

Insights

Electronic health record (EHR)-based machine learning (ML) models significantly improve cardiovascular disease (CVD) risk stratification for secondary prevention. These ML models outperformed traditional risk scores in a multiethnic patient population.

Area of Science:

  • Medical Informatics
  • Cardiology
  • Machine Learning

Background:

  • Effective cardiovascular disease (CVD) prevention relies on accurate identification of high-risk patients.
  • The utility of electronic health record (EHR)-based machine learning (ML) models for CVD risk stratification compared to traditional scores is not well-established.

Purpose of the Study:

  • To compare the performance of EHR-based ML models against the Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention (TRS 2°P) for CVD risk stratification.
  • To evaluate the ability of ML models to predict 5-year CVD event risk in a real-world, multiethnic population.

Main Methods:

  • A cohort of 32,192 patients from a large health system was identified, with 80% used for training and 20% for testing ML models.
  • Various ML models (Random Forests, Gradient-Boosted Machines, XGBoost, Logistic Regression) were trained using EHR data to predict 5-year CVD event risk.
  • Model performance was assessed using the area under the receiver operating characteristic curve (AUC) and compared with TRS 2°P.

Main Results:

  • ML models demonstrated good performance, with XGBoost achieving an AUC of 0.70 in the full CVD cohort and 0.71 in the atherosclerotic CVD (ASCVD) cohort.
  • The traditional TRS 2°P score performed poorly, with AUCs of 0.51 and 0.50 for CVD and ASCVD patients, respectively.
  • ML models identified novel predictive variables, including education level and primary care visit frequency.

Conclusions:

  • EHR-based ML models significantly enhance CVD risk stratification for secondary prevention in a real-world, multiethnic setting.
  • ML approaches offer a superior alternative to traditional risk scores for identifying high-risk patients for CVD prevention strategies.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
396
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
485
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
174
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
200